×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ALVO – alvotech - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ALVO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/23
07:06 am
alvo
Alvotech (NASDAQ:ALVO) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
Alvotech (NASDAQ:ALVO) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
12/22
02:22 am
alvo
Alvotech announces European launch of biosimilar to Simponi [Seeking Alpha]
Medium
Report
Alvotech announces European launch of biosimilar to Simponi [Seeking Alpha]
12/22
02:20 am
alvo
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma [Yahoo! Finance]
Medium
Report
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma [Yahoo! Finance]
12/22
02:00 am
alvo
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma
Medium
Report
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma
12/21
09:11 am
alvo
Alvotech (ALVO): Firm Reaffirms 2025 Growth Outlook [Yahoo! Finance]
Medium
Report
Alvotech (ALVO): Firm Reaffirms 2025 Growth Outlook [Yahoo! Finance]
12/19
06:54 pm
alvo
Alvotech Investor News: Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO
Low
Report
Alvotech Investor News: Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO
12/19
06:15 am
alvo
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea® [Yahoo! Finance]
Low
Report
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea® [Yahoo! Finance]
12/19
05:12 am
alvo
Alvotech, Teva reach settlement with Regeneron over Eylea biosimilar AVT06 in U.S. [Seeking Alpha]
Low
Report
Alvotech, Teva reach settlement with Regeneron over Eylea biosimilar AVT06 in U.S. [Seeking Alpha]
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/24
10:19 am
alvo
Form 6-K Alvotech For: Nov 24
Medium
Report
Form 6-K Alvotech For: Nov 24
11/20
07:45 am
alvo
Form 6-K Alvotech For: Nov 20
Medium
Report
Form 6-K Alvotech For: Nov 20
11/17
07:04 am
alvo
Form 6-K Alvotech For: Nov 12
Medium
Report
Form 6-K Alvotech For: Nov 12
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: